Harmony Biosciences Holdings, Inc.
HRMY · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $868M | $715M | +21.5% |
| Operating income | $208M | $191M | +9.2% |
| Net income | $159M | $145M | +9.1% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $269M | $240M | +12.3% |
| Operating income | $54.2M | $65.5M | −17.3% |
| Net income | $48.2M | $50.9M | −5.3% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Harmony Biosciences's revenue in FY2025?
- $868M in FY2025 (Fiscal year ended Dec 31, 2025), +21.5% vs $715M a year earlier, per its 10-K filed Feb 2026.
- Was Harmony Biosciences profitable in FY2025?
- Yes: net income was $159M and operating income $208M in FY2025.
- What was Harmony Biosciences's revenue in Q3 2026?
- $269M (+12.3% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.